Smash that machine.
Ro Khanna
 @RoKhanna
Jan 3
No, Johnson & Johnson should not be allowed to charge leukemia patients $160,000 per year for IMBRUVICA while raking in a gross yearly profit of $65 billion. Any surprise that J&J is now trying to sue the government for letting Medicare negotiate lower drug prices. We need to stop Big Pharma's price gouging.

Jan 4, 2024 · 6:42 AM UTC

29
119
3
573
Replying to @marwilliamson
Healthcare and Medicine are essential ... taxpayer researched medicine needs to be put out to bid and produced for Americans at cost. With the public holding the patent. Big Pharma forced to compete. No more free taxpayer funded research. If they refuse, nationalize them.
4
Replying to @marwilliamson
JNJ lost a ton of money last year. This doesn't ring as true anymore. We need to find a way to keep our producers and consumers protected.
1
Replying to @marwilliamson
Yeah but the vaccine! The new left loves big Pharma
3
Replying to @marwilliamson
Faaaaack!!!!
2
Replying to @marwilliamson
Check who the Board of Directors are for this company. What party backs this company up? Hum!
2
Replying to @marwilliamson
#OpFukushima #StopTEPCO #DontNukeThePacific
1
Replying to @marwilliamson
Would be very interested to know how their "R&D" costs were calculated, and both their distribution projections and "supply commitments" were accountable in their cost/profit calculations.
1
1
Replying to @marwilliamson
‼️‼️‼️
2
GIF
Replying to @marwilliamson
#MedicareForAll
2
4
Load more